Role of Metallothionein in Post-Burn Inflammation

Inflammation. 2016 Apr;39(2):768-74. doi: 10.1007/s10753-016-0305-7.

Abstract

Metallothioneins (MTs) are a family of low molecular-weight and cysteine-rich metalloproteins that regulate metal metabolism and protect cells from oxygen free radicals. Recent studies suggested that MTs have some anti-inflammatory effects. However, the role of MTs in post-burn inflammation remains unclear. This study is designed to investigate the role of MTs in post-burn inflammation in a mouse burn model. MT-I/II null (-/-) and C57BL/6 wild-type (WT) mice were randomly divided into sham burn, burn, Zn treated, and Zn-MT-2 treated groups. The inflammatory cytokines levels were measured by enzyme-linked immunosorbent assay (ELISA). Myeloperoxidase (MPO) activity was determined by spectrophotometry. In in vitro study, exogenous MT-2 was added to macrophages that were stimulated with burn serum in the presence or absence of a p38 MAPK inhibitor SB203580. The IL-6 and TNF-α messenger RNA (mRNA) expression were detected by quantitative real-time polymerase chain reaction. The levels of p38 expression were determined by Western blot. Burn induced increased inflammatory cytokines such as interleukin (IL)-1β, IL-6, tumor necrosis factors-α, and macrophage chemoattractant protein-1 production in burn wound and serum. The MPO activities in the lung and heart were also increased after burn. These effects were significantly more prominent in MT (-/-) mice than in WT mice. Furthermore, these effects were inhibited by administration of exogenous MT-2 to both WT and MT (-/-) mice. Exogenous MT-2 inhibited the p38 expression and abrogated the increase of IL-6 and TNF-α mRNA expression from macrophages that were stimulated with burn serum. The effect of MT-2 was not further strengthened in the presence of SB203580. MTs may have a protective role against post-burn inflammation and inflammatory organ damage, at least partly through inhibiting the p38 MAPK signaling.

Keywords: burn; inflammation; metallothionein; p38.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Burns / pathology*
  • Chemokine CCL2 / blood
  • Chemokine CCL2 / metabolism
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Imidazoles / pharmacology
  • Inflammation / pathology*
  • Interleukin-1beta / blood
  • Interleukin-1beta / metabolism
  • Interleukin-6 / blood
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • MAP Kinase Signaling System / immunology*
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Male
  • Metallothionein / genetics
  • Metallothionein / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Peroxidase / metabolism
  • Pyridines / pharmacology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Real-Time Polymerase Chain Reaction
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / genetics
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • p38 Mitogen-Activated Protein Kinases / biosynthesis

Substances

  • Ccl2 protein, mouse
  • Chemokine CCL2
  • IL1B protein, mouse
  • Imidazoles
  • Interleukin-1beta
  • Interleukin-6
  • Pyridines
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Metallothionein
  • Peroxidase
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580